Cargando…
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269709/ https://www.ncbi.nlm.nih.gov/pubmed/32504543 http://dx.doi.org/10.1016/S0140-6736(20)31290-3 |
| _version_ | 1783541806215987200 |
|---|---|
| author | The Lancet Editors |
| author_facet | The Lancet Editors |
| author_sort | The Lancet Editors |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7269709 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72697092020-06-05 Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis The Lancet Editors Lancet Article Elsevier Ltd. 2020-06-03 /pmc/articles/PMC7269709/ /pubmed/32504543 http://dx.doi.org/10.1016/S0140-6736(20)31290-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article The Lancet Editors Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title | Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title_full | Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title_fullStr | Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title_full_unstemmed | Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title_short | Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis |
| title_sort | expression of concern: hydroxychloroquine or chloroquine with or without a macrolide for treatment of covid-19: a multinational registry analysis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269709/ https://www.ncbi.nlm.nih.gov/pubmed/32504543 http://dx.doi.org/10.1016/S0140-6736(20)31290-3 |
| work_keys_str_mv | AT thelanceteditors expressionofconcernhydroxychloroquineorchloroquinewithorwithoutamacrolidefortreatmentofcovid19amultinationalregistryanalysis |